Rule 4729:4-1-06 | Requirements for approved monitoring programs.
(A) An approved monitoring program, as defined in rule 4729:4-1-01 of the Administrative Code, must be approved by the state board of pharmacy and shall meet or exceed the following requirements:
(1) Have board approved policies and procedures which shall include, but not be limited to, the following:
(a) The program's standards and procedures for care;
(b) The program's standards and training/approval process for personnel.
(2) Have personnel including, but not limited to, an intervenor and a designated person as defined in rule 4729:4-1-01 of the Administrative Code.
(B) An intervenor associated with an approved monitoring program shall:
(1) Respond to information from concerned individuals;
(2) Ascertain validity of the information received;
(3) Assess the situation and, if the licensee or registrant is showing evidence of impairment, the intervenor shall refer the individual for evaluation;
(4) If the licensee or registrant fails to comply within one week to a referral for evaluation, the intervenor must report the name of the licensee or registrant to the board within one business day.
(C) The designated person for the limited approved treatment provider shall:
(1) Ensure confidentiality of the impaired licensee or registrant, except:
(a) If the licensee or registrant fails to comply within one week to a referral for evaluation; or
(b) If the impaired licensee or registrant suffers a relapse at any time during or following rehabilitation.
(2) Notify the state board of pharmacy within one business day if the licensee or registrant violates any portion of this rule.
Last updated September 11, 2023 at 11:42 AM
Supplemental Information